These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21584488)

  • 1. Transcription factor decoy against NFATc1 in human primary osteoblasts.
    Penolazzi L; Lisignoli G; Lambertini E; Torreggiani E; Manferdini C; Lolli A; Vecchiatini R; Ciardo F; Gabusi E; Facchini A; Gambari R; Piva R
    Int J Mol Med; 2011 Aug; 28(2):199-206. PubMed ID: 21584488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts.
    Penolazzi L; Zennaro M; Lambertini E; Tavanti E; Torreggiani E; Gambari R; Piva R
    Mol Pharmacol; 2007 Jun; 71(6):1457-62. PubMed ID: 17389747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
    Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
    Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts.
    Ali MM; Yoshizawa T; Ishibashi O; Matsuda A; Ikegame M; Shimomura J; Mera H; Nakashima K; Kawashima H
    J Cell Sci; 2007 Aug; 120(Pt 15):2565-73. PubMed ID: 17623776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts.
    Naot D; Chhana A; Matthews BG; Callon KE; Tong PC; Lin JM; Costa JL; Watson M; Grey AB; Cornish J
    Bone; 2011 Aug; 49(2):217-24. PubMed ID: 21515435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
    Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
    J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFAT and Osterix cooperatively regulate bone formation.
    Koga T; Matsui Y; Asagiri M; Kodama T; de Crombrugghe B; Nakashima K; Takayanagi H
    Nat Med; 2005 Aug; 11(8):880-5. PubMed ID: 16041384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
    Lambertini E; Penolazzi L; Giordano S; Del Senno L; Piva R
    Biochem J; 2003 Jun; 372(Pt 3):831-9. PubMed ID: 12659635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.
    Zhou B; Wu B; Tompkins KL; Boyer KL; Grindley JC; Baldwin HS
    Development; 2005 Mar; 132(5):1137-46. PubMed ID: 15689382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFATc1 activates the acetylcholinesterase promoter in rat muscle.
    Cohen TV; Randall WR
    J Neurochem; 2004 Sep; 90(5):1059-67. PubMed ID: 15312161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif.
    Shimizu E; Matsuda-Honjyo Y; Samoto H; Saito R; Nakajima Y; Nakayama Y; Kato N; Yamazaki M; Ogata Y
    J Cell Biochem; 2004 Apr; 91(6):1183-96. PubMed ID: 15048873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene.
    Lambertini E; Penolazzi L; Aguiari G; del Senno L; Pezzetti F; Sollazzo V; Piva R
    Biochem Biophys Res Commun; 2002 Apr; 292(3):761-70. PubMed ID: 11922631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
    Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
    J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: minimal role of the proximal E-box cis-acting promoter elements.
    Quarles LD; Siddhanti SR; Medda S
    J Cell Biochem; 1997 Apr; 65(1):11-24. PubMed ID: 9138076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp7/Osterix is involved in the up-regulation of the mouse pro-α1(V) collagen gene (Col5a1) in osteoblastic cells.
    Wu YF; Matsuo N; Sumiyoshi H; Yoshioka H
    Matrix Biol; 2010 Oct; 29(8):701-6. PubMed ID: 20888414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells.
    Xiao ZS; Hinson TK; Quarles LD
    J Cell Biochem; 1999 Sep; 74(4):596-605. PubMed ID: 10440929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
    Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
    Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.
    Akimzhanov A; Krenacs L; Schlegel T; Klein-Hessling S; Bagdi E; Stelkovics E; Kondo E; Chuvpilo S; Wilke P; Avots A; Gattenlöhner S; Müller-Hermelink HK; Palmetshofer A; Serfling E
    Am J Pathol; 2008 Jan; 172(1):215-24. PubMed ID: 18156209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.